Skip to main content
2024 ISPE Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Sandra Lopez Leon, MD PhD

Director Pharmacoepidemiologist
Novartis Pharma
East Hanover, United States

Sandra Lopez-Leon MD PhD FISPE Co-Chair of Pregnancy and Lactation SIG MiPAL
She a genetic pharmacoepidemiologist focused on studying the safety of new neuropsychiatric medications at all stages of drug development. She graduated from the Erasmus University Medical Center in the Netherlands with the degrees of Master in Science, Doctor in Science, and a Ph.D. in Genetic Epidemiology. Since 2013, she works at Novartis Pharmaceuticals as a pharmacoepidemiologist in the department of Quantitative Safety & Epidemiology under Global Drug Development. Dr Lopez-Leon conducts pharmacoepidemiological studies using large administrative claims databases, electronic health records and population registries to evaluate the safety of medications. Her research proficiencies include study design, research methodology, statistical analyses, meta-analyses and the interpretation of study results. In addition, she leads a working group in the IMI ConcePTION consortium, which aims to build an ecosystem for improved monitoring and communicating of the safety of medicine use in pregnancy and breastfeeding. Dr Lopez-Leon has authored over 60 peer-reviewed scientific publications and four books. She peer-reviews for numerous journals, serves on the editorial board of BMC Research Notes, and is a member of the International Society for Pharmacoepidemiology (ISPE) and of the Psychiatric Genetic Latin American Consortium. Since 2019, she has been a Preceptor at Novartis for fellows training at the Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS).

Disclosure information not submitted.

Presentation(s):

Email Sandra